Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Technology Platform and System Construction of Clinical Evaluation Studies on New Drugs of Hematological Malignancy

NCT01250808 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT01250808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01250808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Technology Platform and System Construction of Clinical Evaluation Studies on New Drugs of Hematological Malignancy
Lead sponsor
Peking University
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma